What are the long‑term effects of amlodipine 5 mg daily?

Long-Term Effects of Amlodipine 5 mg Daily

Amlodipine 5 mg daily demonstrates sustained antihypertensive efficacy and cardiovascular protection over long-term use (up to 24 months studied), with excellent tolerability and no development of tolerance.

Sustained Blood Pressure Control

Amlodipine 5 mg provides consistent 24-hour blood pressure reduction without loss of efficacy over time. The drug maintains blood pressure control throughout the entire dosing interval with minimal peak-trough variation, and tolerance does not develop even after 1 year of continuous use 1. In long-term studies extending to 27 months, amlodipine produced statistically significant reductions averaging 30.5/20.7 mmHg in systolic/diastolic pressure 2.

The pharmacokinetic profile supports this sustained effect—amlodipine has a half-life of 35-50 hours and extremely low renal clearance (7 mL/min/mg), allowing once-daily dosing with protection even if an occasional dose is missed 3.

Cardiovascular Outcomes

Long-term amlodipine therapy provides meaningful cardiovascular protection beyond blood pressure reduction:

• In the CAMELOT trial, amlodipine reduced composite cardiovascular events by 31% (hazard ratio 0.691, p=0.003) over 19 months 1
• Fewer hospitalizations for angina and reduced need for revascularization procedures
• In patients with coronary artery disease, sustained improvement in exercise performance and reduction in angina attacks over 24 months 4
• No adverse effects on cardiac pump function or heart rate during exercise 5

Hemodynamic Effects

Amlodipine reduces total peripheral resistance by approximately 19% without compromising cardiac output 5. The drug maintains stroke volume and cardiac index at rest and during exercise, with no reflex tachycardia—a significant advantage over other dihydropyridines. Heart rate remains stable during long-term therapy 1, 5.

Metabolic Neutrality

A critical long-term advantage: amlodipine does not adversely affect insulin sensitivity, glucose metabolism, or lipid profiles even after 6 months of treatment in obese hypertensive patients 6. This metabolic neutrality makes it particularly suitable for patients with diabetes or metabolic syndrome.

Safety Profile

The long-term safety profile is favorable:

• Peripheral edema occurs in only 1.2-17% of patients on 5 mg doses 2, 7
• Most side effects are mild to moderate and often resolve with continued treatment
• No clinically significant changes in laboratory parameters, ECG, or renal function 2, 6
• No evidence of carcinogenicity in 2-year animal studies 1
• Well-tolerated in elderly patients, with particular benefit for stroke prevention 3

Specific Clinical Contexts

For hypertension with coronary disease: Amlodipine 5-10 mg provides dual benefit—blood pressure control plus reduction in angina frequency and improved exercise tolerance maintained over 20+ months 4.

For heart failure with reduced ejection fraction: Exercise caution. While the PRAISE trials showed no mortality benefit, amlodipine can be used when needed for persistent hypertension or angina despite guideline-directed medical therapy, but it should not be used routinely 8.

For pediatric hypertension: In children aged 6-17 years, amlodipine 2.5-5 mg daily produces sustained blood pressure reduction (approximately 3-5 mmHg systolic) with adverse events similar to adults 9, 1.

Important Caveats

• Do not use amlodipine empirically in pulmonary arterial hypertension without documented acute vasoreactivity testing—inappropriate use can cause severe hypotension and right ventricular failure 10
• Avoid in patients with severe left ventricular dysfunction or decompensated heart failure 8
• The 5 mg dose is generally well-tolerated; the 10 mg dose increases the risk of peripheral edema

Practical Considerations

Start with 2.5-5 mg daily and titrate to effect. The long half-life means steady-state is reached in 7-8 days, so allow adequate time before dose adjustments. Blood pressure control persists even with occasional missed doses due to the extended duration of action 3. The once-daily dosing and low side effect profile enhance long-term adherence 2.